0KSX Stock Overview
Provides diagnostic testing and services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$162.75 |
| 52 Week High | US$162.75 |
| 52 Week Low | US$123.31 |
| Beta | 0.89 |
| 11 Month Change | 3.25% |
| 3 Month Change | 6.82% |
| 1 Year Change | 20.15% |
| 33 Year Change | 11.02% |
| 5 Year Change | 51.38% |
| Change since IPO | 52.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0KSX | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 3.5% | -1.3% | 0.7% |
| 1Y | 20.2% | -23.6% | 6.1% |
Return vs Industry: 0KSX exceeded the UK Healthcare industry which returned -23.6% over the past year.
Return vs Market: 0KSX exceeded the UK Market which returned 6.1% over the past year.
Price Volatility
| 0KSX volatility | |
|---|---|
| 0KSX Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0KSX has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0KSX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 44,000 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| 0KSX fundamental statistics | |
|---|---|
| Market cap | US$18.01b |
| Earnings (TTM) | US$838.00m |
| Revenue (TTM) | US$9.54b |
21.8x
P/E Ratio1.9x
P/S RatioIs 0KSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0KSX income statement (TTM) | |
|---|---|
| Revenue | US$9.54b |
| Cost of Revenue | US$6.39b |
| Gross Profit | US$3.15b |
| Other Expenses | US$2.31b |
| Earnings | US$838.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.51 |
| Gross Margin | 32.97% |
| Net Profit Margin | 8.79% |
| Debt/Equity Ratio | 90.3% |
How did 0KSX perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield39%
Payout RatioDoes 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Jan 14 2025 |
| Dividend Pay Date | Jan 29 2025 |
| Days until Ex dividend | 53 days |
| Days until Dividend pay date | 68 days |
Does 0KSX pay a reliable dividends?
See 0KSX dividend history and benchmarks